Literature DB >> 25612856

Percutaneous versus surgical management of lower extremity peripheral artery disease.

Amit M Kakkar1, J Dawn Abbott.   

Abstract

Lower extremity peripheral artery disease (PAD) is highly prevalent and can manifest as intermittent claudication or, in the most advanced form, critical limb ischemia. Revascularization, which can be accomplished by an endovascular or surgical approach, is performed to improve quality of life or, in severe cases, for limb salvage. Over the past decade, percutaneous catheter-based techniques have improved such that acute procedural success is high even in complex anatomy. Patency rates have also increased with the use of atherectomy devices and drug-eluting stents. Often, patients with PAD have comorbidities that increase the risk of cardiovascular complications with surgical procedures. These factors have led to the adoption of an endovascular first strategy with surgical management reserved for selected patients. This review focuses on the most current clinical trials of endovascular therapy for PAD. In addition, older but relevant studies comparing endovascular and surgical approaches and contemporary surgical trials are presented for reference.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25612856     DOI: 10.1007/s11883-014-0479-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  71 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received.

Authors:  Andrew W Bradbury; Donald J Adam; Jocelyn Bell; John F Forbes; F Gerry R Fowkes; Ian Gillespie; Charles Vaughan Ruckley; Gillian M Raab
Journal:  J Vasc Surg       Date:  2010-05       Impact factor: 4.268

3.  SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use.

Authors:  Bruce H Gray; Larry J Diaz-Sandoval; Robert S Dieter; Michael R Jaff; Christopher J White
Journal:  Catheter Cardiovasc Interv       Date:  2014-07-18       Impact factor: 2.692

4.  Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia.

Authors:  Gagan D Singh; Ehrin J Armstrong; Khung-Keong Yeo; Satinder Singh; Gregory G Westin; William C Pevec; David L Dawson; John R Laird
Journal:  J Vasc Surg       Date:  2014-01-03       Impact factor: 4.268

5.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.

Authors:  M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

6.  Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States.

Authors:  Elizabeth M Mahoney; Kaijun Wang; Hong H Keo; Sue Duval; Kim G Smolderen; David J Cohen; Gabriel Steg; Deepak L Bhatt; Alan T Hirsch
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-10-12

7.  Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000.

Authors:  Patrice L Anderson; Annetine Gelijns; Alan Moskowitz; Ray Arons; Lopa Gupta; Alan Weinberg; Peter L Faries; Roman Nowygrod; K Craig Kent
Journal:  J Vasc Surg       Date:  2004-06       Impact factor: 4.268

8.  One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA "STEnting Long de L'Artère fémorale superficielle" cohort).

Authors:  J-M Davaine; L Azéma; B Guyomarch; P Chaillou; A Costargent; P Patra; G Lambert; Y Gouëffic
Journal:  Eur J Vasc Endovasc Surg       Date:  2012-08-21       Impact factor: 7.069

9.  Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group.

Authors:  E Tetteroo; Y van der Graaf; J L Bosch; A D van Engelen; M G Hunink; B C Eikelboom; W P Mali
Journal:  Lancet       Date:  1998-04-18       Impact factor: 79.321

10.  Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial.

Authors:  Richard R Saxon; Arun Chervu; Paul A Jones; Tanvir K Bajwa; Dennis R Gable; Peter A Soukas; Richard J Begg; John G Adams; Gary M Ansel; Darren B Schneider; Charles M Eichler; Michael J Rush
Journal:  J Vasc Interv Radiol       Date:  2013-01-28       Impact factor: 3.464

View more
  2 in total

1.  Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty.

Authors:  I-Chih Chen; Chao-Chin Yu; Yi-Hsuan Wu; Ting-Hsing Chao
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

2.  3D-printed vascular networks direct therapeutic angiogenesis in ischaemia.

Authors:  T Mirabella; J W MacArthur; D Cheng; C K Ozaki; Y J Woo; M Yang; C S Chen
Journal:  Nat Biomed Eng       Date:  2017-06-13       Impact factor: 25.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.